Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 11439
Country/Region: Haiti
Year: 2009
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Own Agency
Funding Agency: HHS/CDC
Total Funding: $300,000

Funding for Treatment: Adult Treatment (HTXS): $300,000

Summary: With Fiscal Year (FY) 2009 funding, CDC will continue to strengthen the system of HIV care and

treatment in Haiti by focusing on assisting the Ministry of Health (MOH) and stakeholders, to plan,

coordinate and supervise different QA/QI programs. This activity will build on CDC's efforts to hire care and

treatment and information technology (IT) regional specialists. This activity will also add to the MOH's efforts

to provide human resources and logistic support to reinforce departmental directorates for better

coordination and supervision at the departmental level. Allocated resources will be used to hire CDC

regional specialists, as well as to cover logistic costs and per diem for their travel and participation in

training (both within and outside of the country).


As the treatment program is expanded, the United States Government (USG) is reinforcing coordination,

supervision and QA/QI at all levels. Resources are given to the MOH departmental directorates to build a

team that could oversee and supervise the treatment program at the departmental level. Regional hospitals

are being reinforced with mobile teams that the USG expects to become the technical arm of the

departmental directorates in mentoring and supervising peripheral sites. In addition, HIVQUAL has provided

resources to work with the MOH to launch a standard national system of QA/QI with adequate tools to

collect data and ensure continued improvement in the provision of treatment services. CDC will reinforce, at

the departmental level, the technical capacity for coordination, training, and mentoring particularly in the

regional public departmental hospitals which suffer from serious lack of human resources.

So far, three physicians, specialized in internal medicine, have been hired to fill the care and treatment

specialist positions in three departments (South, Grand'Anse and South East) working under the

supervision of the CDC/Haiti care and treatment specialist. These regional specialists have been very active

in making rounds within the internal medicine and infectious disease units of HIV care at the departmental

hospitals. They are providing technical support (hands on training and supervision) to expand care and

treatment to satellite sites and are working with the departmental staff to coordinate the program. As the

QA/QI program is rolled out through HIVQUAL, these specialists will play an important role in its

implementation. Treatment program funds have been used to support the costs of in-country travel for these

specialists. Funds have also been used to support training costs outside of the country as well.

With FY 2009 resources, three new treatment regional specialists will be hired and based in three additional

departments: North, Artibonite and North West. The resources planned through this activity narrative will be

used to cover salaries of the six regional specialists as well as their travel costs for supervising and

participating in training in and outside of the country for continuing education purposes. Part of these

resources will be used also to cover travel costs for health professionals from the MOH and other partners

who will be invited to participate in PEPFAR's international gatherings.

New/Continuing Activity: Continuing Activity

Continuing Activity: 17239

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

17239 10242.08 HHS/Centers for US Centers for 7701 3141.08 $300,000

Disease Control & Disease Control

Prevention and Prevention

10242 10242.07 HHS/Centers for US Centers for 5154 3141.07 $905,000

Disease Control & Disease Control

Prevention and Prevention

Table 3.3.09: